Ruchi Medical Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 10-12-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 10.83 Cr
as on 10-12-2024
- Satisfied Charges ₹ 8.10 Cr
as on 10-12-2024
- Revenue -46.45%
(FY 2021)
- Profit -81.38%
(FY 2021)
- Ebitda -45.33%
(FY 2021)
- Net Worth 3.60%
(FY 2021)
- Total Assets 11.39%
(FY 2021)
About Ruchi Medical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹10.83 Cr. The company has closed loans amounting to ₹8.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Rastogi, Shweta Rastogi, Ajay Rastogi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232UR2012PTC000489
- Company No.
000489
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ruchi Medical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Rastogi  | Director | 04-Dec-2012 | Current |
| Shweta Rastogi | Director | 04-Dec-2012 | Current |
| Ajay Rastogi | Director | 23-Mar-2013 | Current |
| Anjana Rastogi | Director | 23-Mar-2013 | Current |
Financial Performance of Ruchi Medical.
Ruchi Medical Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 46.45% decrease. The company also saw a substantial fall in profitability, with a 81.38% decrease in profit. The company's net worth moved up by a moderate rise of 3.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ruchi Medical?
In 2019, Ruchi Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ruchimed Retail Ventures LlpActive 7 years 8 monthsNeeraj Rastogi and Shweta Rastogi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 13 Mar 2020 | ₹10.83 Cr | Open |
Others Creation Date: 08 Feb 2019 | ₹8.10 Cr | Satisfied |
How Many Employees Work at Ruchi Medical?
Unlock and access historical data on people associated with Ruchi Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ruchi Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruchi Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
